<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tissue P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> immunostaining was performed in seventy one patients with follicular large, mixed, or small cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Only six patients (8.5%) demonstrated positive immunostaining for P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had complete and durable responses to initial therapy </plain></SENT>
<SENT sid="3" pm="."><plain>P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (<z:chebi fb="14" ids="53218">MDR</z:chebi>) fails to predict for primary drug resistance in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and is constitutionally expressed in only a few follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> at present </plain></SENT>
</text></document>